PK

Pradeep Kumar Sahal

Active Director Director DIN 07911071
DIN 07911071 First appointment Aug 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Aug 2017
Shareholding value •••• Premium profile

About Pradeep Kumar Sahal

Data last updated:

Pradeep Kumar Sahal is a Director at Supravitz Lifesciences Private Limited (since 2017), Director at Nuramed Pharmaceuticals Private Limited (since 2022) and Designated Partner at Nuramed Lifesciences Llp (since 2022). The companies operate in Healthcare, Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹21.82 Cr; the largest is Supravitz Lifesciences Private Limited at ₹16.30 Cr (FY 2025).

DIN 07911071
Primary Designation Director
Industry Healthcare
First Appointment 25 Aug 2017
Oldest Company Age 9 yrs
Largest company Supravitz Lifesciences Private Limited · ₹16.30 Cr (FY 2025)
Combined revenue ₹21.82 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20172017₹16.30 Cr (FY 2025)Active
Director14 Oct 20222022₹5.52 Cr (FY 2025)Active
Designated Partner29 May 20222022Active

Directorship timeline

Open interactive timeline →
Supravitz Lifesciences Private Limited
Nuramed Pharmaceuticals Private Limited
Nuramed Lifesciences Llp
Premium access

Shareholding and investment profile for Pradeep Kumar Sahal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradeep Kumar Sahal

Pradeep Kumar Sahal currently holds 3 directorships: Supravitz Lifesciences Private Limited (Director, since 25 Aug 2017, revenue ₹16.30 Cr (FY 2025)); Nuramed Pharmaceuticals Private Limited (Director, since 14 Oct 2022, revenue ₹5.52 Cr (FY 2025)); Nuramed Lifesciences Llp (Designated Partner, since 29 May 2022).

Pradeep Kumar Sahal was first appointed on 25 Aug 2017 as Director at Supravitz Lifesciences Private Limited. The most recent appointment on record is 14 Oct 2022 at Nuramed Pharmaceuticals Private Limited.

The 2 current companies of Pradeep Kumar Sahal that report revenue have a combined latest revenue of ₹21.82 Cr: Supravitz Lifesciences Private Limited ₹16.30 Cr (FY 2025); Nuramed Pharmaceuticals Private Limited ₹5.52 Cr (FY 2025).

The current boards of Pradeep Kumar Sahal's companies include Dipak Kumar Tibrewal (Supravitz Lifesciences Private Limited), Rajesh Kumar Agarwal (Supravitz Lifesciences Private Limited), Nitin Rammilan Tiwari (Nuramed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available